LEEDer Group Inc.
8508 North West 66th St.
Miami, Florida 33166 USA

Phone: 305.436.5030
Fax: 305.436.0086
E-mail Address: info {at] LEEDerGroup [dot] com

2012-06 Final Decision Memorandum for Transcutaneous Electrical Nerve Stimulation for Chronic Low Back Pain (CAG-00429N)

NOTE: 2012-08, see Update
TO: Administrative File: (CAG #00429N)
FROM: Louis Jacques, MD Director, Coverage and Analysis Group
Tamara Syrek Jensen, JD Deputy Director, Coverage and Analysis Group
James Rollins, MD, MSHA, PhD Director, Division of Items and Devices
Brijet Burton, MPP, MS, PA-C Lead Analyst, Division of Items and Devices
Rosemarie Hakim, PhD Epidemiologist
Susan Miller, MD Lead Medical Officer

  • SUBJECT: Final Decision Memorandum for Transcutaneous Electrical Nerve Stimulation for Chronic Low Back Pain (CAG-00429N) DATE: June 8, 2012
    I. Final Decision:
    A. Definitions
    For the purposes of this decision CLBP is defined as:
    an episode of low back pain that has persisted for three months or longer; and
    is not a manifestation of a clearly defined and generally recognizable primary disease entity. For example, there are cancers that, through metastatic spread to the spine or pelvis, may elicit pain in the lower back as a symptom; and certain systemic diseases such as rheumatoid arthritis and multiple sclerosis manifest many debilitating symptoms of which low back pain is not the primary focus.
    B. TENS is not reasonable and necessary for the treatment of CLBP under section 1862(a)(1)(A) of the Social Security Act.